Device And Rare Disease Lobbies Expect Continued Bipartisan Support

The Advanced Medical Technology Association (AdvaMed) and the National Organization for Rare Disorders (NORD) are confident that the interests of their constituencies will be well represented despite the shift from a GOP-led to Democrat-led House, plus some changes in the Senate, after the midterm elections. Spokespeople for the groups say they owe their optimism to robust bipartisan backing of several recent bills such as the Orphan Products Extension Now Accelerating Cures and Treatments Act (OPEN ACT) and the Protecting Medical...